Insulet
PODD
#1416
Rank
$11.83 B
Marketcap
$169.25
Share price
3.20%
Change (1 day)
-40.18%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Operating Margin for Insulet (PODD)

Operating Margin as of March 2024 (TTM): 0.75%

According to Insulet's latest financial reports and stock price the company's current Operating Margin is 0.75%. At the end of 2022 the company had an Operating Margin of 0.75%.

Operating Margin history for Insulet from 2012 to 2011

Operating Margin at the end of each year

Year Operating Margin Change
20220.75%-59.76%
20211.87%73.95%
20201.07%-45.4%
20191.96%111.92%
20180.93%-116.18%
2017-5.73%-21.59%
2016-7.31%-68.59%
2015-23.26%30.78%
2014-17.79%-2.06%
2013-18.16%-25.68%
2012-24.44%-34.77%
2011-37.47%6.22%
2010-35.27%-60.76%
2009-89.89%-63.72%
2008-247.77%-38.47%
2007-402.65%-57.43%
2006-945.81%-97.8%
2005-43,010.00%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
22.88% 2,950.67%๐Ÿ‡บ๐Ÿ‡ธ USA
15.60% 1,980.00%๐Ÿ‡บ๐Ÿ‡ธ USA
17.17% 2,189.33%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
24.66% 3,188.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-25.16%-3,454.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-5.01%-768.00%๐Ÿ‡บ๐Ÿ‡ธ USA
13.43% 1,690.67%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.